These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Survival and morbidity outcomes after pelvic exenteration for pelvic sarcoma: an institutional series. Lee PJ; Meshkat B; Sasidharan P; Zahid A; Coker DJ; Solomon MJ ANZ J Surg; 2022 May; 92(5):1038-1043. PubMed ID: 34661958 [TBL] [Abstract][Full Text] [Related]
8. Retrospective review of pelvic malignancies undergoing total pelvic exenteration. Kuhrt MP; Chokshi RJ; Arrese D; Martin EW World J Surg Oncol; 2012 Jun; 10():110. PubMed ID: 22703863 [TBL] [Abstract][Full Text] [Related]
9. [Observational study on perioperative outcomes of pelvic exenteration]. Yuan H; Yao B; Li JT; Zhu WL; Ren DL; Wang H; Ma TH; Chen SQ; Wu JJ; Tao YR; Ye L; Wang ZY; Qu H; Ma B; Zhong WW; Wang DJ; Qiu JG Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Mar; 26(3):260-267. PubMed ID: 36925126 [No Abstract] [Full Text] [Related]
10. Outcomes of Pelvic Exenteration with en Bloc Partial or Complete Pubic Bone Excision for Locally Advanced Primary or Recurrent Pelvic Cancer. Austin KK; Herd AJ; Solomon MJ; Ly K; Lee PJ Dis Colon Rectum; 2016 Sep; 59(9):831-5. PubMed ID: 27505111 [TBL] [Abstract][Full Text] [Related]
11. Short- and long-term outcomes following pelvic exenteration for gynae-oncological and colorectal cancers: A 9 year consecutive single-centre cohort study. Katory M; McLean R; Paez E; Kucukmetin A; Naik R Int J Surg; 2017 Jul; 43():38-45. PubMed ID: 28529192 [TBL] [Abstract][Full Text] [Related]
12. Pushing the boundaries of pelvic exenteration by maintaining survival at the cost of morbidity. Venchiarutti RL; Solomon MJ; Koh CE; Young JM; Steffens D Br J Surg; 2019 Sep; 106(10):1393-1403. PubMed ID: 31282571 [TBL] [Abstract][Full Text] [Related]
13. Total pelvic exenteration for primary and recurrent malignancies. Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811 [TBL] [Abstract][Full Text] [Related]
14. A prospective investigation of pain and fatigue following pelvic exenteration. Vuong K; Alchin LM; Solomon MJ; Koh CE; Steffens D Eur J Surg Oncol; 2021 Dec; 47(12):3137-3143. PubMed ID: 34366173 [TBL] [Abstract][Full Text] [Related]
15. Contemporary outcomes of total pelvic exenteration in the treatment of colorectal cancer. Jimenez RE; Shoup M; Cohen AM; Paty PB; Guillem J; Wong WD Dis Colon Rectum; 2003 Dec; 46(12):1619-25. PubMed ID: 14668586 [TBL] [Abstract][Full Text] [Related]
16. Complications and 5-year survival after radical resections which include urological organs for locally advanced and recurrent pelvic malignancies: analysis of 646 consecutive cases. Peacock O; Waters PS; Kong JC; Warrier SK; Wakeman C; Eglinton T; Murphy DG; Heriot AG; Frizelle FA; McCormick JJ Tech Coloproctol; 2020 Feb; 24(2):181-190. PubMed ID: 31907722 [TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of pelvic exenteration for locally advanced primary or recurrent non-colorectal pelvic malignancies. Ueda T; Koyama F; Nakagawa T; Nakamura S; Nishigori N; Inoue T; Kawasaki K; Obara S; Nakamoto T; Fujii H; Nakajima Y Gan To Kagaku Ryoho; 2013 Nov; 40(12):2433-6. PubMed ID: 24394136 [TBL] [Abstract][Full Text] [Related]